Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03183102 · ClinicalTrials.gov registry record · NA
The Role of the Gut Microbiota in Estrogen Metabolism and Dietary Flax as a Potential Modulator.
A NA study of Menopause, sponsored by Colorado State University.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT03183102: Completed NA study of Menopause, sponsored by Colorado State University.
NCT03183102 is a NA study of Menopause that has completed, run by Colorado State University. The registered enrollment target is 30 participants, below the 9,394-participant average among 54 other Menopause trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03183102, a NA study of Menopause, has completed, sponsored by Colorado State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this pilot study is to determine if suppressing estrogen in premenopausal women results in changes in gut microbiota and if dietary flaxseed modulates these changes.
Primary Outcome
16s rRNA sequencing--Illumina MiSeq
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Flaxseed
Study Locations (1)
Colorado
- Colorado State University - Fort Collins
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-10-01 |
| Est. Completion | 2022-12-30 |
| Phase | NA |
What the finished NCT03183102 record still lists
NCT03183102 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 9,394-participant average among 54 other Menopause trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Menopause appearing as the primary indexed condition, and to 1 intervention - of which Flaxseed is the first listed.
NCT03183102 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT03183102 about?
NCT03183102 is a clinical study titled "The Role of the Gut Microbiota in Estrogen Metabolism and Dietary Flax as a Potential Modulator.". The purpose of this pilot study is to determine if suppressing estrogen in premenopausal women results in changes in gut microbiota and if dietary flaxseed modulates these changes.
What is the current status of trial NCT03183102?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2017-10-01. Estimated completion is 2022-12-30.
What conditions does trial NCT03183102 study?
This clinical trial studies the following conditions: Menopause.
What interventions are being tested in trial NCT03183102?
The interventions under investigation include: Flaxseed (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03183102?
This trial is sponsored by Colorado State University, which has 94 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03183102 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Menopause
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03183102's enrollment target sits among peer trials
30 41st of 54 higher than 11 of 54 other Menopause trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Menopause trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Hot Flashes and Neurovascular Function in Women
RECRUITING · NA
-
Efficacy and Safety of Shatavari for Treatment of Menopausal Symptoms in Women: A Randomized, Double-blind, Three-arm, Parallel, Placebo-controlled Study
RECRUITING · NA
-
Improving Sympathetic Activity, Hot Flashes, and Sleep in Midlife Women Using Inspiratory Muscle Strength Training
RECRUITING · NA
-
Exercise Training Intensity and Nitrate Supplementation in Post-Menopausal Females
RECRUITING · NA
-
Depression, Aging, Stress and Heart Health Study
RECRUITING · NA
-
Choline Dose Ranging in Postmenopausal Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI